Clinical trial

Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC

NCT06536868

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-08-01

PhasePHASE2

Study timeline

Study start (actual)2024-08-01Date precision: day

Registry last updated2026-04-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Extensive-stage Small-cell Lung Cancerunresolved

Interventions

TislelizumabDRUG · verified · RxNorm: tislelizumab

EtoposideDRUG · verified · RxNorm: etoposide

Carboplatin or CisplatinDRUG

Thoracic radiotherapyRADIATION

Sponsors & collaborators

Second Hospital of Shanxi Medical Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06536868 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.